Table 1 Clinical features of the 36 MTC patients

No.	Sex	MTC type	Ki67% primary tumour	Tumour diameter (mm)	Tumour stage pTNM	Age at operation (years)	Postoperative survival (years)	Status at follow-up
1	F	H^*	0.01	5	III	24.89	14.06	Alive
2	M	S	0.03	18	III	59.16	17.26	Died O.C.†
3	F	H	0.05	60	II	35.14	49.11	Alive
4	M	S	0.09	27	II	43.75	26.13	Alive
5	M	S	0.19	50	III	49.90	17.25	Died O.C.†
6	F	S	0.20	10	III	41.41	26.91	Alive
7	F	S	0.23	45	IV	29.30	19.19	Died MTC
8	M	H	0.24	55	II	31.95	14.23	Alive
9	M	H	0.24	4	I	18.73	22.69	Alive
10	F	S	0.26	5	I	48.61	18.18	Alive
11	F	S	0.26	22	III	74.19	8.61	Died MTC
12	F	S	0.27	13	III	60.84	29.61	Alive
13	F	S	0.30	20	II	55.29	18.60	Alive
14	F	H	0.31	5	III	31.55	16.08	Alive
15	F	S	0.32	40	III	38.65	24.40	Alive
16	M	H	0.33	60	III	41.84	6.49	Died MTC
17	M	H	0.34	20	IV	59.32	2.65	Died MTC
18	M	H	0.36	47	III	30.06	22.60	Died MTC
19	F	H	0.46	13	III	42.38	12.77	Alive
20	F	S	0.46	40	IV	30.84	5.07	Died MTC
21	F	H	0.49	30	II	22.19	10.61	Alive
22	F	H	0.56	25	III	38.13	13.06	Alive
23	F	S	0.59	42	III	50.64	9.54	Died MTC
24	F	S	0.62	45	II	66.43	6.95	Died MTC
25	M	S	0.63	45	III	38.41	20.07	Alive
26	F	H	0.73	15	III	65.38	10.11	Alive
27	F	H	0.75	4	III	18.58	16.30	Alive
28	M	S	0.77	40	III	47.56	10.05	Died MTC
29	F	S	0.85	25	III	39.81	19.71	Alive
30	M	S	0.88	12	III	63.84	12.38	Alive
31	M	S	1.12	50	III	43.45	25.32	Alive
32	F	S	1.27	47	III	62.49	16.6	Alive
33	M	S	1.84	70	III	59.16	7.65	Died MTC
34	M	S	2.58	Missing	IV	56.78	1.79	Died MTC
35	M	S	3.51	37	IV	64.27	1.09	Died MTC
36	M	S	4.5	50	IV	47.72	0.64	Died MTC

H=hereditary; MTC, S=sporadic MTC; died O.C. ^†=died of other causes than MTC; pTNM=postsurgical histopathological classsification; T=tumour; N=regional lymph node metastasis; m=distant metastasis.

Quick links

Search